Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | GlobalData Reports | Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015

Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015

Summary

GlobalData’s “Atrial Fibrillation Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global atrial fibrillation market. The report identifies the key trends shaping and driving the dynamism in the global atrial fibrillation market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. The report also analyses the M&A landscape in the global atrial fibrillation market with special focus on the market participants that have been the most M&A active. Most importantly, the report provides valuable insight on the pipeline products within the global atrial fibrillation sector.

Scope

- Annualized global atrial fibrillation market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.

- Analysis and review of the key events and milestones that will impact the future of the global atrial fibrillation market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.

- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global atrial fibrillation market in the long run.

- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.

- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global atrial fibrillation market.

- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global atrial fibrillation market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.Pages: 35Publication Date: 2009 April
Table of Contents
Price: $2,000.00 / €1,336.80

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions